Tang Minjie, the executive director and chief financial officer, increased his holding of Hao Hai Biology Technology (06826.HK) by 10,000 shares at a price of HK$24.86 per share.

According to the Zhitong finance and economics app, the latest data from the Hong Kong Stock Exchange shows that on December 16th, Tang Minjie, Executive Director and Chief Financial Officer, increased his holdings of Hao Hai Biotechnology (06826.HK) by 10,000 shares at a price of HK$24.86 per share, totaling approximately HK$248,600. After the increase, the latest number of shares held is approximately 35,400 shares, with a latest shareholding ratio of 0.09%.